| NCT ID | NCT05867186 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johannes Gutenberg University Mainz |
| Condition | Pediatric Oncology |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-06-20 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-06-20 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the influence of exercise on physical performance and psychosocial aspects in children and adolescents with cancer during and after treatment.
Eligibility Criteria
Inclusion Criteria: * Oncological disease according to the International Classification of Childhood Cancer. * Planned or started anti-cancer treatment (chemo- and/or radiotherapy and/or surgery) at the Clinic and Polyclinic for Paediatrics and Adolescent Medicine of the University Medical Centre of the Johannes Gutenberg University Mainz or connection to the Paediatric Oncology Centre Mainz within the framework of aftercare. * The patient is assessed by the treating team (pediatric oncologist, exercise professional etc.) as suitable to participate in the trial, e.g. due to medical or psychological reasons. * Existing informed consent (or assent) to participate in the study. * The patient is not in a terminal phase of the disease. Exclusion criteria: * The patient is assessed by the treating team (pediatric oncologist, exercise professional etc.) as unsuitable to participate in the trial, e.g. due to medical or psychological reasons. * After detailed information and, if necessary, having time to consider, the patient (≥ 16 years of age) did not agree to give written informed consent to participate in the trial. In the case of minor patients (\<16 years of age): The legal guardians do not assume that the child/adolescent is able to freely decide on participation or to consent to participation on the basis of the information received, and do not consent to this themselves. * The patient (and the legal guardians) has/have insufficient knowledge of the German or English language, so that it is not possible to carry out both the informed consent and interviews (in age-appropriate language). * The patient is in a terminal phase of the disease.
Contact & Investigator
Joerg Faber, Univ.-Prof. Dr. med.
PRINCIPAL INVESTIGATOR
Johannes-Gutenberg-University Medical Center
Frequently Asked Questions
Who can join the NCT05867186 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 21 Years, studying Pediatric Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05867186 currently recruiting?
Yes, NCT05867186 is actively recruiting participants. Contact the research team at fortee@unimedizin-mainz.de for enrollment information.
Where is the NCT05867186 trial being conducted?
This trial is being conducted at Mainz, Germany.
Who is sponsoring the NCT05867186 clinical trial?
NCT05867186 is sponsored by Johannes Gutenberg University Mainz. The principal investigator is Joerg Faber, Univ.-Prof. Dr. med. at Johannes-Gutenberg-University Medical Center. The trial plans to enroll 100 participants.